Publication Name	World Journal of Cardiology
Manuscript ID	64015
Country	Croatia

Received	2021-02-07 16:17
Peer-Review Started	2021-02-07 16:26
To Make the First Decision
Return for Revision	2021-02-28 17:11
Revised	2021-03-01 18:49
Second Decision	2021-03-24 05:48
Accepted by Journal Editor-in-Chief	2021-03-25 10:32
Accepted by Executive Editor-in-Chief	2021-03-30 04:20
Articles in Press	2021-03-30 04:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-08 08:51
Publish the Manuscript Online	2021-04-21 09:34

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dentistry, Oral Surgery & Medicine
Manuscript Type	Opinion Review
Article Title	Drug-induced gingival overgrowth in cardiovascular patients
Manuscript Source	Invited Manuscript
All Author List	Lucija Bajkovec, Anna Mrzljak, Robert Likic and Ivan Alajbeg
Funding Agency and Grant Number
Corresponding Author	Anna Mrzljak, FEBG, PhD, Associate Professor, Department of Medicine, Merkur University Hospital, Zajceva 19, Zagreb 10000, Croatia. anna.mrzljak@gmail.com
Key Words	Drug-induced gingival overgrowth; Calcium channel blocker; Nifedipine; Calcineurin inhibitor; Cyclosporin; Cardiovascular
Core Tip	Drug-induced gingival overgrowth is a side-effect of the drugs such as calcium channel blockers and immunosuppressants, commonly used in cardiovascular and transplanted patients. The condition is multifactorial and mainly depends on the potential of the used drug to cause gingival changes and the state of oral hygiene. Patients who develop drug-induced gingival overgrowth may experience severe discomfort and pain in addition to troubles with mastication, speech, and maintaining oral hygiene. Since it significantly reduces the quality of life, preventive and curative measures should be implemented as part of a care plan for patients at risk.
Publish Date	2021-04-21 09:34
Citation	Bajkovec L, Mrzljak A, Likić R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol 2021; 13(4): 68-75
URL	https://www.wjgnet.com/1949-8462/full/v13/i4/68.htm
DOI	https://dx.doi.org/10.4330/wjc.v13.i4.68

Full Article (PDF)	WJC-13-68.pdf
Full Article (Word)	WJC-13-68.docx
Manuscript File	64015_Auto_Edited_LM.docx
Answering Reviewers	64015-Answering reviewers.pdf
Audio Core Tip	64015-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64015-Conflict-of-interest statement.pdf
Copyright License Agreement	64015-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64015-Language certificate.pdf
Peer-review Report	64015-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	64015-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	64015-Scientific misconduct check.pdf
Scientific Editor Work List	64015-Scientific editor work list.pdf
CrossCheck Report	64015-CrossCheck report.pdf